Patient Blood Articles & Analysis

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced the opening of a United States subsidiary in the Denver metropolitan area. The new office will increase logistical and commercial support for PixCell's U.S. clients and will handle order fulfilment across the country, as well as provide additional clinical and technical support to customers. "Opening a ...

By PixCell Medical Technologies

Rarecells Inc., a leading Liquid Biopsy company is pleased to announce the development of an innovative and accurate targeted digital single-cell Next-Generation Sequencing (scNGS) for single-nucleotide variant (SNV) method to detect mutant genes of pancreatic ductal adenocarcinoma (PDAC) circulating tumor cells (CTC) enriched by the ISET® technology. A peer-reviewed article, published in ...

By Rarecells Diagnostics SAS

NanoPin Technologies, Inc., whose mission is to develop advanced diagnostics to improve the lives of millions of individuals affected by infectious disease, announces the formation of a collaboration with Thermo Fisher Scientific to refine the liquid chromatography mass spectrometry (LCMS)-based workflow to allow robust and highly sensitive clinical application of NanoPin’s proprietary ...

By NanoPin Technologies Inc.

Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, recently rolled out their cutting-edge real-time PCR kits for Hepatitis A virus (HAV) research. The new kits offer researchers excellent accuracy, sensitivity, and convenience in studying and analyzing HAV samples. Hepatitis A is a highly contagious viral ...

By Amerigo Scientific

COPENHAGEN, Denmark--(BUSINESS WIRE)--Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the company’s NEURESCUE® device for temporary occlusion of large vessels, including patients requiring emergency ...

By Neurescue

Oak Ridge, TN – March 23, 2023 — Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces new pilot randomized control trial (RCT) data from Duke Heart validating the greater accuracy of the Company’s BVA-100 diagnostic in optimizing decongestion therapy for heart failure patients and pointed to a strong signal toward reducing ...

By Heart Failure Society of America, Inc. (HFSA)

ORANGE COUNTY, Calif., Sept. 21, 2021 /CNW/ — The World Health Organization (WHO) has just featured MediPines AGM100®, pulmonary gas exchange analyzer as an innovative technology in their 2021 compendium, “WHO compendium of innovative health technologies for low-resource settings”. This year’s annual assessment report provided much needed global awareness for ...

By MediPines

Calviri, Inc., a biotech startup spun out of Arizona State University Biodesign Institute, focused on ending deaths from cancer, today announced the closing of $2.25 million in seed round funding. The funding is from five private investors including Dr. Jacque Sokolov, a Calviri Board member, and Dr. Mitzi Krockover. Calviri was founded based on the discovery that tumors make frequent and ...

By Calviri

Calviri, Inc., a biotech startup spun out of Arizona State University Biodesign Institute, focused on prevention and treatment of cancer, announced results that demonstrate the potential of a prophylactic vaccine against cancer. The study of RNA processing errors in tumors highlighted that a large number of frameshift neoantigens are produced. This new class of neoantigens are shown to be ...

By Calviri

The Start-up Nation has made several ground breaking discoveries in the fields of technology, science, and innovation during the past decade.The first artificial pancreas – A potential cure for diabetes? In a possible future cure for diabetes, researchers at Betalin Therapeutics have engineered the first artificial pancreas. It can be inserted underneath the skin, without anesthesia and ...

By Betalin Therapeutics Ltd.

We are pleased to announce that MediPines AGM100, a non-invasive pulmonary gas exchange analyzer, was selected as a finalist in the 2021 Medical Design Excellence Awards (MDEA). The MDEAs is the premier design competition in the MedTech industry organized by MD+DI and recognizes the significant achievements in medical product design and engineering that improve the quality of healthcare delivery ...

By MediPines

Last month, OSHA announced that agency investigators would increase their focus on a set of new key hazards for the healthcare industry during upcoming inspections. These hazards will aim to address musculoskeletal disorders related to patient or resident handling; blood borne pathogens; workplace violence; tuberculosis and slips, trips and falls. To those in the healthcare industry, this ...

By Intelex Technologies Inc.

Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces new data validating the benefits of the Company’s BVA-100 blood test (BVA) in improving survival for advanced heart failure patients with left ventricular assist device (LVAD). These data were presented at the International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and ...

By Daxor Corporation

Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS. Elevated levels of limonene in patients have been found to be indicative of a diseased liver. Especially in the UK liver disease has risen sharply over the past few decades and is the third biggest cause of premature mortality. Patients do not ...

By Ionicon Analytik Ges.m.b.H.

Human factors and usability are becoming more and more prevalent in the design and development process. So much so, that many organisations are placing a focus on the human factors element of their product development. But, is it a necessary inclusion or simply an added benefit? At eg technology, we live and breathe integrated end-to-end development. So, for us, the answer is simple. Human ...

By eg Technology Ltd

Babson Diagnostics, a science-first, health care technology company, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of a strategic partnership to move blood sample collection into new care settings, including enabling patients to collect blood samples at home for diagnostic testing. Since 2019, the two companies ...

By Babson Diagnostics

For most of us, getting blood drawn is an unpleasant, but necessary, part of life. For others, though, it’s extremely risky, if not impossible. Those people have what is known as difficult venous access (DVA), and they can include children, people witjh chronic illnesses, the elderly and people with diabetes, among others. Velano Vascular is a company that has developed a way to draw blood ...

By Velano Vascular

Key Research Survey Findings: 52 percent of healthcare providers agreed motivation is a major barrier to patients adhering to blood glucose monitoring compared to only 10 percent of people with diabetes who agreed motivation is a major barrier. Healthcare providers claimed they are recommending blood glucose management apps to only 25 percent of their patients, while 55% of patients who ...

By LifeScan

Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that ApolloMed received certification from the National Committee for Quality Assurance ("NCQA") for ...

By Apollo Medical Holdings, Inc.

Four Patients With ALS Who Received Stentrode™ Implant Gained Ability to Perform Daily Online Tasks No Serious Adverse Events Reported after 12 Months Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ device, a small mesh-like material inserted ...

By Synchron, Inc.